ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 486

IRF5 Promotes Arthritis but Restricts Virus Replication and Spread during Chikungunya Virus Infection

Jonathan Miner1, Amber Smith2, Raeann Shimak2 and Michael Diamond3, 1Internal Medicine / Rheumatology, Washington University in Saint Louis School of Medicine, Saint Louis, MO, 2Washington University in Saint Louis School of Medicine, Saint Louis, MO, 3Medicine / Infectious Diseases, Washington University in Saint Louis School of Medicine, Saint Louis, MO

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: cytokines, inflammatory arthritis, innate immunity, interferons and viruses

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2016

Title: Rheumatoid Arthritis – Animal Models - Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Chikungunya virus (CHIKV) is an arthritogenic alphavirus that invades the joints and causes chronic arthritis in up to 60% of infected individuals. Over the last two years, approximately 2 million people have been infected with CHIKV in the Western Hemisphere. The symptoms and immunological features of CHIKV arthritis mimic phenotypes observed in patients with untreated rheumatoid arthritis. Interferon regulatory factors (IRF) including IRF5 contribute to anti-viral immunity, but polymorphisms leading to over-expression of IRF5 increase the risk of developing rheumatologic disease. Thus, we reasoned that IRF5 expression may modulate the pathogenesis of CHIKV infection including the risk of developing severe CHIKV arthritis.

Methods: IRF5 knockout mice and wild-type control animals were infected with a highly pathogenic La Reunion strain of CHIKV and then monitored for virus replication, spread, and clinical features of disease including joint swelling, cytokine production, and leukocyte infiltration.

Results:  We found that expression of IRF5 restricts CHIKV dissemination to distal joints, but at the expense of triggering more severe acute CHIKV arthritis. IRF5 expression was associated with enhanced cytokine production and leukocyte infiltration into the joints of infected animals.

Conclusion: IRF5 restricts CHIKV dissemination and promotes acute arthritis in mice. These findings suggest that over-expression of IRF5 in humans may limit the spread of arthritogenic alphaviruses to distal joints, but at the cost of promoting more severe clinical disease during the acute phase of infection.


Disclosure: J. Miner, None; A. Smith, None; R. Shimak, None; M. Diamond, None.

To cite this abstract in AMA style:

Miner J, Smith A, Shimak R, Diamond M. IRF5 Promotes Arthritis but Restricts Virus Replication and Spread during Chikungunya Virus Infection [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/irf5-promotes-arthritis-but-restricts-virus-replication-and-spread-during-chikungunya-virus-infection/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/irf5-promotes-arthritis-but-restricts-virus-replication-and-spread-during-chikungunya-virus-infection/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology